We announced a strategic partnership to expand our innovative probiotics portfolio in the Middle East with an exclusive agreement with Cigalah Medpharm. The Fertibiome and Flowbiotic brands will reach 6 countries in the Middle East, which will strengthen our presence in these countries enabling us to meet the growing demand for high quality probiotic solutions focused on digestive and fertility health.

Cigalah Medpharm is a leading company dedicated to providing innovative, high-quality products that address a wide range of healthcare needs.
As a subsidiary of the Cigalah Group, part of the prestigious Yousuf M.A. Naghi & Sons Group, Cigalah Medpharm represents global brands in pharmaceuticals, cosmetics, and healthcare seeking to establish a strong presence in the region.